Cyclosporine versustacrolimus: cost-effectiveness analysis for renal transplantation in Brazil
Fuente:
Redalyc
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artículo científico |
| Sprache: | en |
| Veröffentlicht: |
Universidade de São Paulo
2015
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1876474281134653440 |
|---|---|
| author | Augusto Afonso Guerra Júnior |
| author_facet | Augusto Afonso Guerra Júnior |
| contents | Cyclosporine versustacrolimus: cost-effectiveness analysis for renal transplantation in Brazil Augusto Afonso Guerra Júnior Grazielle Dias Silva Eli Iola Gurgel Andrade Mariângela Leal Cherchiglia Juliana de Oliveira Costa Alessandra Maciel Almeida Francisco de Assis Acurcio Salud Cost economics drug effects Graft Survival Cohort Studies OBJECTIVE: To analyze the cost-effectiveness of treatment regimens with cyclosporine or tacrolimus, five years after renal transplantation.METHODS: This cost-effectiveness analysis was based on historical cohort data obtained between 2000 and 2004 and involved 2,022 patients treated with cyclosporine or tacrolimus, matched 1:1 for gender, age, and type and year of transplantation. Graft survival and the direct costs of medical care obtained from the National Health System (SUS) databases were used as outcome results.RESULTS: Most of the patients were women, with a mean age of 36.6 years. The most frequent diagnosis of chronic renal failure was glomerulonephritis/nephritis (27.7%). In five years, the tacrolimus group had an average life expectancy gain of 3.96 years at an annual cost of R$78,360.57 compared with the cyclosporine group with a gain of 4.05 years and an annual cost of R$61,350.44.CONCLUSIONS: After matching, the study indicated better survival of patients treated with regimens using tacrolimus. However, regimens containing cyclosporine were more cost-effective. 2015 artículo científico 0034-8910 https://www.redalyc.org/articulo.oa?id=67240213009 en http://www.redalyc.org/revista.oa?id=672 Revista de Saúde Pública application/pdf Universidade de São Paulo Revista de Saúde Pública (Brasil) Vol.49 |
| format | Artículo científico |
| id | redalyc_67240213009 |
| institution | Redalyc |
| language | en |
| publishDate | 2015 |
| publisher | Universidade de São Paulo |
| spellingShingle | Cyclosporine versustacrolimus: cost-effectiveness analysis for renal transplantation in Brazil Augusto Afonso Guerra Júnior Salud Cost economics drug effects Graft Survival Cohort Studies Cyclosporine versustacrolimus: cost-effectiveness analysis for renal transplantation in Brazil Augusto Afonso Guerra Júnior Grazielle Dias Silva Eli Iola Gurgel Andrade Mariângela Leal Cherchiglia Juliana de Oliveira Costa Alessandra Maciel Almeida Francisco de Assis Acurcio Salud Cost economics drug effects Graft Survival Cohort Studies OBJECTIVE: To analyze the cost-effectiveness of treatment regimens with cyclosporine or tacrolimus, five years after renal transplantation.METHODS: This cost-effectiveness analysis was based on historical cohort data obtained between 2000 and 2004 and involved 2,022 patients treated with cyclosporine or tacrolimus, matched 1:1 for gender, age, and type and year of transplantation. Graft survival and the direct costs of medical care obtained from the National Health System (SUS) databases were used as outcome results.RESULTS: Most of the patients were women, with a mean age of 36.6 years. The most frequent diagnosis of chronic renal failure was glomerulonephritis/nephritis (27.7%). In five years, the tacrolimus group had an average life expectancy gain of 3.96 years at an annual cost of R$78,360.57 compared with the cyclosporine group with a gain of 4.05 years and an annual cost of R$61,350.44.CONCLUSIONS: After matching, the study indicated better survival of patients treated with regimens using tacrolimus. However, regimens containing cyclosporine were more cost-effective. 2015 artículo científico 0034-8910 https://www.redalyc.org/articulo.oa?id=67240213009 en http://www.redalyc.org/revista.oa?id=672 Revista de Saúde Pública application/pdf Universidade de São Paulo Revista de Saúde Pública (Brasil) Vol.49 |
| title | Cyclosporine versustacrolimus: cost-effectiveness analysis for renal transplantation in Brazil |
| topic | Salud Cost economics drug effects Graft Survival Cohort Studies |
| url | https://www.redalyc.org/articulo.oa?id=67240213009 |